ChemoCentryx to Present at Two Upcoming Investor Conferences
MOUNTAIN VIEW, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences in August: BTIG Virtual Biotech
GlobeNewswire · 1天前
ChemoCentryx to Hold Second Quarter 2020 Financial Results Conference Call on Monday, August 10, 2020
MOUNTAIN VIEW, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2020 financial results will be released after market close on Monday, August 10, 2020. ChemoCentryx executive managem
GlobeNewswire · 2天前
Insiders Roundup: Mastercard, ChemoCentryx
GuruFocus.com · 07/17 16:02
Did Hedge Funds Make The Right Call On ChemoCentryx Inc (CCXI) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of
Insider Monkey · 07/13 14:43
Insiders Roundup: Mastercard, Eli Lilly
GuruFocus.com · 07/10 16:11
ChemoCentryx Submits New Drug Application to the U.S. FDA for Avacopan in ANCA-Associated Vasculitis
GlobeNewswire · 07/09 13:30
ChemoCentryx files U.S. avacopan application for blood vessel inflammation
Seeking Alpha - Article · 07/09 12:45
ChemoCentryx Submits New Drug Application To FDA For Avacopan In ANCA-Associated Vasculitis